Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Drugs (New York, N.Y.), 2015-01, Vol.75 (1), p.33-59 [Peer Reviewed Journal]

Springer International Publishing Switzerland 2014 ;Copyright Springer Science & Business Media Jan 2015 ;ISSN: 0012-6667 ;ISSN: 1179-1950 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-014-0337-y ;PMID: 25488697

Full text available